MedTrace Logo

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

NCT04634916 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2026-03-27

No results posted yet for this study

Summary

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

Conditions

  • Kidney Disease, End-Stage
  • End-stage Renal Disease
  • Arteriovenous Fistula

Interventions

DEVICE

EndoAVF Creation

Subjects will have an endoAVF created using the WavelinQ EndoAVF System

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Eric Peden, MD · The Methodist Hospital Research Institute

  • Paul Kreienberg, MD · Albany Medical College

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-26
Primary Completion
2027-06-30
Completion
2027-09-30
FDA Device
Yes

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04634916 on ClinicalTrials.gov